Signal Genetics Inc. NASDAQ: SGNL $4.80http://www.marketwatch.com/investing/Stock/SGNL/profile?Coun... Company Description Signal Genetics, Inc., headquartered in New York, NY, is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. Its mission is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions. The company was founded in January 2010 and became the exclusive licensee in its licensed field to the renowned research on multiple myeloma performed at the University of Arkansas for Medical Sciences, or UAMS, in April 2010. #SGNL WEBSITE: https://www.signalgenetics.com/